Kawasaki syndrome (Q80431719)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15302199%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

review article

1 reference

title

Kawasaki syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15302199%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Jane C Burns

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15302199%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Mary P Glodé

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15302199%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

English

0 references

publication date

1 August 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15302199%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15302199%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

364

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15302199%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

9433

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15302199%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

533-544

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15302199%20AND%20SRC:MED&resulttype=core&format=json

Commentary: translation of Dr. Tomisaku Kawasaki's original report of fifty patients in 1967.

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Kawasaki disease: A brief history.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Kawasaki disease before kawasaki at Tokyo university hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Rethinking the boundaries of Kawasaki disease: toward a revised case definition.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Adult coronary artery disease probably due to childhood Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Sequelae of Kawasaki disease in adolescents and young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Kawasaki disease: more patients are being diagnosed who do not meet American Heart Association criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Cerebrospinal fluid profile in patients with acute Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Elevated gamma-glutamyltransferase concentrations in patients with acute Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

The differentiation of classic Kawasaki disease, atypical Kawasaki disease, and acute adenoviral infection: use of clinical features and a rapid direct fluorescent antigen test

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Incomplete Kawasaki disease with coronary artery involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Incidence and clinical features of incomplete Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Ultrasonographic evaluation of cervical lymph nodes in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Clinical spectrum of Kawasaki disease in infants younger than 6 months of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Kawasaki disease in infants less than one year of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Kawasaki disease in older children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Kawasaki Disease in the Older Child

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Rising incidence of Kawasaki disease in England: analysis of hospital admission data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Kawasaki syndrome hospitalizations in the United States, 1997 and 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Kawasaki syndrome: association with the application of rug shampoo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Association of rug shampooing and Kawasaki disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Kawasaki syndrome in Washington State. Race-specific incidence rates and residential proximity to water

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Kawasaki syndrome clusters in Harris County, Texas, and eastern North Carolina. A high endemic rate and a new environmental risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Investigation of Kawasaki syndrome risk factors in Colorado

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Search for Highly Conserved Viral and Bacterial Nucleic Acid Sequences Corresponding to an Etiologic Agent of Kawasaki Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Superantigens, conventional antigens and the etiology of Kawasaki syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Oligoclonal IgA response in the vascular wall in acute Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Vascular endothelial growth factor in acute Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Increased serum levels of vascular endothelial growth factor in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Circulating interleukin-1 beta in patients with Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Evaluation of the cytokine response in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Expression of IL-8 in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

CD14+CD16+ monocyte subpopulation in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Maturation of macrophages from peripheral blood monocytes in Kawasaki disease: immunocytochemical and immunoelectron microscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Activation of peripheral blood monocytes and macrophages in Kawasaki disease: ultrastructural and immunocytochemical investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Inflammatory pulmonary nodules in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

High-dose intravenous gammaglobulin for Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Early treatment with intravenous immunoglobulin in patients with Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Late intravenous gamma globulin treatment in infants and children with Kawasaki disease and coronary artery abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Immune inhibitory receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Effect of high doses of intravenously administered immune globulin on natural killer cell activity in peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Modulation of endothelial cell function by normal polyspecific human intravenous immunoglobulins: a possible mechanism of action in vascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Kawasaki disease: who is at risk?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Initial intravenous gammaglobulin treatment failure in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Longstanding Obliterative Panarteritis in Kawasaki Disease: Lack of Cyclosporin A Effect

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Ticlopidine plus aspirin for coronary thrombosis in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Does Abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Images in cardiovascular medicine. Kawasaki disease: coronary aneurysms in mother and son

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Two-generation Kawasaki disease: mother and daughter

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Immunoglobulin allotypic markers in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

High incidence of angiotensin I converting enzyme genotype II in Kawasaki disease patients with coronary aneurysm

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Analysis of tumor necrosis factor-alpha production and polymorphisms of the tumor necrosis factor-alpha gene in individuals with a history of Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Polymorphism of transmembrane region of MICA gene and Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Methylenetetrahydrofolate reductase polymorphism in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Monocyte chemoattractant protein 1 gene regulatory region polymorphism and serum levels of monocyte chemoattractant protein 1 in Japanese patients with Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Interleukin 6 gene promoter polymorphism is not associated with Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Increased frequency of alleles associated with elevated tumor necrosis factor-alpha levels in children with Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Polymorphism of SLC11A1 (formerly NRAMP1) gene confers susceptibility to Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Association of mannose-binding lectin genotype with cardiovascular abnormalities in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Valvular heart disease in Kawasaki syndrome: incidence and natural history

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Cross-sectional echocardiographic diagnosis of coronary artery aneurysms in patients with the mucocutaneous lymph node syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Sensitivity, specificity and predictive value of two-dimensional echocardiography in detecting coronary artery aneurysms in patients with Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Guidelines for catheter intervention in coronary artery lesion in Kawasaki disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Catheter interventional treatment in Kawasaki disease: A report from the Japanese Pediatric Interventional Cardiology Investigation group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

The role of coronary bypass operation on children with Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Cardiac Transplantation for Kawasaki Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Left ventricular contractility and function in Kawasaki syndrome. Effect of intravenous gamma-globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Circulating cardiac troponin I levels in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Myocarditis in Kawasaki syndrome. A minor villain?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Kawasaki disease: review of risk factors for coronary aneurysms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Intravenous γ-Globulin Treatment in Kawasaki Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Mortality among patients with a history of Kawasaki disease: the third look. The Kawasaki Disease Follow-up Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Hemodynamic factors of thrombus formation in coronary aneurysms associated with Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Transthoracic ultrasonic visualisation of coronary aneurysm, stenosis, and occlusion in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Functional behavior and morphology of the coronary artery wall in patients with Kawasaki disease assessed by intravascular ultrasound.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Transthoracic Doppler assessment of coronary flow velocity reserve in children with Kawasaki disease: comparison with coronary angiography and thallium-201 imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Coronary magnetic resonance angiography in adolescents and young adults with kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Dobutamine stress echocardiography in the evaluation of young patients with Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Noninvasive evaluation of myocardial ischemia in Kawasaki disease: comparison between dipyridamole stress thallium imaging and exercise stress testing

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Discordance between thallium-201 scintigraphy and coronary angiography in patients with Kawasaki disease: myocardial ischemia with normal coronary angiogram

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Pathological study of postcoronary arteritis in adolescents and young adults: with reference to the relationship between sequelae of Kawasaki disease and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Quantification of myocardial blood flow and flow reserve in children with a history of Kawasaki disease and normal coronary arteries using positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Exercise capacity and incidence of myocardial perfusion defects after Kawasaki disease in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Endothelial dysfunction late after Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Cardiovascular risk factors after Kawasaki disease: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Aortic root dilation in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

Long-term consequences of Kawasaki disease among first-year junior high school students

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916814-1

7 January 2021

10.1016/S0140-6736(04)16814-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15302199%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15302199%20AND%20SRC:MED&resulttype=core&format=json